Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Monoclonal”

2,823 trials

Showing 20 of 2,823 results

Early research (Phase 1)Study completedNCT00575562
What this trial is testing

Phase I Study of KRN330 Monoclonal Antibody in Patients With Colorectal Cancer

Who this might be right for
Colorectal Cancer
Kyowa Kirin, Inc. 42
Large-scale testing (Phase 3)Study completedNCT02181673
What this trial is testing

Golimumab in Participants With Active Psoriatic Arthritis

Who this might be right for
Arthritis, Psoriatic
Janssen Research & Development, LLC 480
Testing effectiveness (Phase 2)Study completedNCT00040586
What this trial is testing

Phase II Trial of Monoclonal Antibody (J591) in Combination With Low-Dose Subcutaneous Interleukin-2

Who this might be right for
Prostatic Neoplasms
BZL Biologics
Early research (Phase 1)Study completedNCT01046266
What this trial is testing

Pharmacodynamics of RO5083945 in Patients With Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Cancer
Hoffmann-La Roche 62
Large-scale testing (Phase 3)Study completedNCT05110261
What this trial is testing

Evaluate the Safety and Efficacy of Nirsevimab in Healthy Preterm and Term Infants in China

Who this might be right for
Lower Respiratory Tract Infection
AstraZeneca 800
Early research (Phase 1)Study completedNCT05118386
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of RSV Monoclonal Antibody RSM01 in Healthy Adults

Who this might be right for
RSV Infection
Gates Medical Research Institute 56
Early research (Phase 1)Study completedNCT00785941
What this trial is testing

IMC-A12 Every 2 Weeks in Patients With Tumors Who No Longer Respond to Treatment or No Treatment is Available

Who this might be right for
Advanced Solid Tumors
Eli Lilly and Company 16
Testing effectiveness (Phase 2)Looking for participantsNCT06967805
What this trial is testing

WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Mediar Therapeutics 164
Testing effectiveness (Phase 2)Study completedNCT00957853
What this trial is testing

Preoperative Treatment With Cetuximab and/or IMC-A12

Who this might be right for
Head and Neck Squamous Cell Carcinoma
M.D. Anderson Cancer Center 16
Early research (Phase 1)Study completedNCT00016237
What this trial is testing

Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous Treatment

Who this might be right for
Bladder CancerKidney CancerLung Cancer
EMD Serono
Early research (Phase 1)Study completedNCT01256073
What this trial is testing

A Safety and Tolerability Extension Trial Assessing Repeated Dosing of Anti-KIR (1-7F9) Human Monoclonal Antibody in Patients With Acute Myeloid Leukaemia

Who this might be right for
Acute Myeloid Leukemia
Innate Pharma 21
Early research (Phase 1)Study completedNCT04464395
What this trial is testing

Study of CPI-006 as Immunotherapy for Hospitalized COVID-19 Patients

Who this might be right for
COVID-19
Corvus Pharmaceuticals, Inc. 30
Testing effectiveness (Phase 2)Ended earlyNCT00508872
What this trial is testing

Folfox-B Study for Patients With Colorectal Liver Metastases

Who this might be right for
Colorectal Liver Metastases
M.D. Anderson Cancer Center 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT04933539
What this trial is testing

Subcutaneous Daratumumab, Once Weekly Carfilzomib, and Dexamethasone (DKd) in Patients With High-Risk Smoldering Multiple Myeloma

Who this might be right for
Multiple Myeloma
National Cancer Institute (NCI) 14
Testing effectiveness (Phase 2)UnknownNCT04165174
What this trial is testing

PD-1 Monoclonal Antibody Plus Apatinib Combined With SBRT in HCC With PVTT

Who this might be right for
HCC
Huazhong University of Science and Technology 20
Testing effectiveness (Phase 2)Ended earlyNCT00365274
What this trial is testing

SGN-30 and Combination Chemotherapy in Treating Patients With Newly Diagnosed Anaplastic Large Cell Lymphoma

Who this might be right for
Anaplastic Large Cell Lymphoma
National Cancer Institute (NCI) 6
Testing effectiveness (Phase 2)Looking for participantsNCT07285213
What this trial is testing

Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody

Who this might be right for
Clostridioides Difficile Infection
AstraZeneca 230
Early research (Phase 1)Study completedNCT01769417
What this trial is testing

Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI4893 in Healthy Adult Subjects

Who this might be right for
Staphylococcus Aureus
MedImmune LLC 85
Testing effectiveness (Phase 2)WithdrawnNCT00004040
What this trial is testing

Monoclonal Antibody Therapy or Biological Therapy in Treating Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma in Remission After Chemotherapy

Who this might be right for
LeukemiaMultiple Myeloma and Plasma Cell Neoplasm
Hoag Memorial Hospital Presbyterian
Early research (Phase 1)Study completedNCT05508100
What this trial is testing

Dose Confirmation and Dose Expansion Phase 1 Study of IO-108 and IO-108 + Anti-PD-1 in Solid Tumors

Who this might be right for
Advanced Solid Tumor
Immune-Onc Therapeutics 38
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation